Magaldrate + Simethicone
Composition
Tablets containing both magaldrate and simethicone typically include magaldrate as the active antacid ingredient alongside simethicone as the active anti-foaming agent, often combined with various inactive ingredients such as binders, fillers, disintegrants, and lubricants to form the tablet and aid in its dissolution and absorption. Specific inactive ingredients may vary depending on the tablet formulation and manufacturer.
Indications
Tablets containing magaldrate and simethicone are indicated for the relief of symptoms associated with gastric hyperacidity, indigestion, heartburn, and gas-related discomfort in the gastrointestinal tract.
Side effects
Constipation, diarrhea
Precautions
Renal impairment
Contraindications
Hypersensitivity
Dosage and administration
As directed by healthcare provider
Countries
USA, India, UK
Available Forms
Tablets, oral suspensions